Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B virus immunopathology

F V Chisari1, C Ferrari

  • 1Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.

Springer Seminars in Immunopathology
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychopharmacological treatment in borderline personality disorder: A pilot observational study in a real-world setting.

Psychiatry research·2020
Same author

Incomplete penetrance in familial Alzheimer's disease with PSEN1 Ala260Gly mutation.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2020
Same author

Use of amyloid PET/CT with <sup>18</sup>F-Florbetaben in the management of patients with Alzheimer's disease.

Hellenic journal of nuclear medicine·2019
Same author

Impact of pre-treatment variables on the completion of <sup>223</sup>radium-dichloride therapy in mCRPC patients with bone metastases.

Hellenic journal of nuclear medicine·2019
Same author

The paleoradiology importance in the study of relics: the unique densitometric analysis of a bone relic of Saint Nicholas.

Hellenic journal of nuclear medicine·2019
Same author

Extra-long and taper-free germanium nanowires: use of an alternative Ge precursor for longer nanostructures.

Nanotechnology·2019
Same journal

Antibody and complement-dependent viral neutralization.

Springer seminars in immunopathology·2020
Same journal

Antibody mediated complement dependent lysis of virus infected cells.

Springer seminars in immunopathology·2020
Same journal

Activating and inhibitory FcgammaRs in autoimmune disorders.

Springer seminars in immunopathology·2006
Same journal

Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.

Springer seminars in immunopathology·2006
Same journal

Fcepsilon- and Fcgamma-receptor signaling in diseases.

Springer seminars in immunopathology·2006
Same journal

Fc gamma receptors and cancer.

Springer seminars in immunopathology·2006
See all related articles

Hepatitis B virus (HBV) infection affects 5% of the world population, leading to liver disease and risks of cirrhosis and cancer. A weak immune response drives viral persistence, hindering clearance and treatment strategies.

Area of Science:

  • Hepatology
  • Immunology
  • Virology

Background:

  • Hepatitis B virus (HBV) infection impacts approximately 5% of the global population, causing necroinflammatory liver disease.
  • Chronic HBV infection elevates the risk of developing cirrhosis and hepatocellular carcinoma.
  • The immune response dictates both viral clearance and pathogenesis in HBV infection.

Purpose of the Study:

  • To analyze the immunological and virological factors contributing to HBV persistence.
  • To explore potential immunotherapeutic and antiviral strategies for chronic HBV infection.

Main Methods:

  • The study reviews existing literature on HBV immunology and virology.
  • It examines the roles of humoral and cellular immune responses in HBV infection.
  • It discusses viral evasion mechanisms and their impact on persistence.

Related Experiment Videos

Main Results:

  • A weak antiviral immune response is the primary cause of HBV viral persistence.
  • Both acute and chronic HBV infections exhibit distinct T cell response profiles.
  • Viral evasion strategies, such as epitope inactivation, contribute to persistence.

Conclusions:

  • Understanding HBV persistence mechanisms is crucial for developing effective treatments.
  • Elucidating the immune response to HBV can lead to novel immunotherapeutic and antiviral strategies.
  • Targeting viral persistence may reduce the risk of life-threatening HBV sequelae like cancer.